More Filters

Defective Drug Recalls Lawyer Philadelphia

Defective Drug Recalls Lawyer Philadelphia

BRETT TESSLER

Defective Drug Recalls Lawyer

Attorney at Law, Brett Tessler is not like any other personal injury or workers’ comp attorney in the Philadelphia.   After meeting with Brett, his reputation for putting his clients’ needs above his own becomes obvious personal injury law.

 Brett received his J.D. from Hofstra University School of Law in 1992.  After being licensed in NJ and PA, Brett founded Brett Tessler & Associates in 2004, with a client-first focus.   Contact our office today to speak with Brett Tessler.

Jonathan Wheeler

Defective Drug Recalls Lawyer

Jonathan founded The Law Offices Of Jonathan Wheeler more than 25 years ago. He wanted to build a firm whose focus was on seeking justice for individuals and businesses throughout Pennsylvania and New Jersey, particularly against larger insurance companies.

He has extensive experience in Personal Injury, Property Damage, and Insurance litigation. He specializes in Construction and First Party insurance claims, Bad Faith litigation, and Insurance Company misconduct.

Jonathan’s legal career began over 40 years ago. In that time, he has tried cases in the Court of Common Pleas of Philadelphia, Bucks, Delaware, Chester, Montgomery, Dauphin, Lehigh, and Northampton Counties. Additionally, he has represented clients in the U.S. District Courts for the Eastern and Middle Districts of Pennsylvania, the Superior Courts of Atlantic, Camden, Burlington, Mercer, Cape May, and Cumberland Counties, New Jersey, and the U.S. District Court for the District of New Jersey.

Today, Jonathan is honored to represent clients throughout the region as Partner at what is now known as Wheeler, DiUlio, & Barnabei.

SEAN BERBERIAN

Defective Drug Recalls Lawyer

Sean Berberian is General Counsel of TopDog Law. Sean brings over 25 years of legal experience in business transactions and commercial litigation. He previously served as General Counsel and Senior Vice President of a public company, where he played a key role in taking the company public in 2018. 

Before holding that role, Sean was a founding partner of White Berberian, PLC, where he worked with clients on business litigation, regulatory matters, and complex transactions. He also spent an earlier part of his career as a litigation partner of a national law firm (now Stinson LLP), handling high-stakes civil litigation—including cases before the U.S. Supreme Court and the Ninth Circuit Court of Appeals. Early in his career, Sean also practiced products liability defense for a national law firm in San Francisco.

 

Sean earned his law degree cum laude from the University of California, Hastings and graduated summa cum laude from Arizona State University’s Barrett Honors College. He is licensed to practice in both Arizona and California and is frequently invited to speak at industry events, bar associations, and law schools on various legal topics.

Alison F. Soloff

Defective Drug Recalls Lawyer

A 1979 Rutgers University graduate, Ms. Alison F. Soloff received her law degree from Temple University in 1981. She is licensed to practice in both Pennsylvania and New Jersey, as well as before the United States District Court for the Eastern District of Pennsylvania and the District of New Jersey.

Ms. Alison F. Soloff is a member of the Philadelphia Trial Lawyers Board of Governors for 2007-2025. She has been honored by selection as a “Super Lawyer” in Pennsylvania from 2005-2025 – an honor that is awarded to only the top 5 percent of all Pennsylvania attorneys. Ms. Soloff has also received an AV Peer Review Rating through Martindale-Hubbell, a distinction awarded by her law peers recognizing her for her expertise, integrity, and professional stature and was named one of the 500 leading Plaintiff’s Lawyers in America by Lawdragon. Ms. Soloff was recently nominated and is now a member of the
National Association of Distinguished Counsel, an organization reserved for the top 1 % of attorneys in the United States.

Patrick T. Doherty, Esq.

Defective Drug Recalls Lawyer

Patrick Doherty, based in Philadelphia, Pennsylvania, is a profoundly accomplished attorney with a passion for upholding justice, fostering client relationships, and driving exceptional legal outcomes. A seasoned practitioner in criminal defense and personal injury law, he has built a career marked by compassion, integrity, and dedication to his clients’ needs.

Mr. Doherty’s unique blend of empathy and expertise stems from his extensive experience and Philadelphia roots. He understands the diverse complexities faced by the individuals in his community, establishing personal connections with each client he represents. His legal journey, initiated at Delaware Law School, encompassed various legal fields, including internships at the District Attorney’s Office of Philadelphia. It was here that he began honing his advocacy skills, successfully arguing cases on behalf of the Commonwealth.

M.J. Snyder

Defective Drug Recalls Lawyer

Individuals accused or convicted of committing a crime choose Law Offices of M.J. Snyder, LLC to represent them in their most vulnerable times — when their freedom and liberties are at stake. They make their decisions based on three main differentiators:

  1. Our reputation for excellence and track record for favorable outcomes in thousands of cases over the past decade of practicing criminal law
  1. Our ability to act fast and to tirelessly pursue justice in their cases with unparalleled investigation and trial preparation efforts
  2. Our commitment to giving honest and accurate legal advice at every stage of the process so that you are fully engaged in your own defense

Edith A. Pearce

Defective Drug Recalls Lawyer

Edith Pearce is an exceptionally smart (she is a member of MENSA) and gifted female personal injury lawyer. Attorney Edith Pearce spent over 10 years working as a lawyer for an insurance company and defense firm before concentrating her practice on injured victims and starting The Pearce Law Firm.

Having grown up in the Philadelphia suburbs, graduating from Villanova University and Temple Law School, Edith is a true “Philadelphia lawyer.” Edith Pearce has been practicing law for over 25 years and is a well-known woman personal injury attorney & legal expert who has appeared on various television programs, including ABC, CN8, NBC 10 News, and Fox 29 News, and is a frequently-invited guest on the Who’s Who In Philly Labor Radio Show on WWDB 860 AM Talk Radio. Edith has been listed by Philadelphia Magazine 10 times starting in June 2005 as a “Super Lawyer”. 

Who Is Responsible for Medication Recalls?

Medication recalls are vital safeguards in the healthcare system, designed to protect patients from potentially harmful drugs. When a medication is found to be defective, contaminated, improperly labeled, or otherwise unsafe, it must be swiftly removed from the market to prevent harm. But who exactly is responsible for these recalls? The process involves multiple parties, each with distinct roles and responsibilities, working together to ensure public safety. Let’s explore the key stakeholders and the steps involved in medication recalls.

1. Drug Manufacturers and Distributors: The First Line of Responsibility

The primary responsibility for medication recalls lies with the companies that manufacture and distribute the drugs. These entities are closest to the production process and are usually the first to detect problems, whether through their own quality control systems, customer complaints, or reports from healthcare professionals.

How Manufacturers Initiate Recalls

  • Detection of Issues: Manufacturers are required to monitor the quality and safety of their products even after they have entered the market. If they discover a problem—such as contamination, incorrect dosage, or labeling errors—they are expected to act quickly.

  • Voluntary Recalls: Most recalls are voluntary. This means the manufacturer or distributor decides to remove the product from the market without being ordered to do so by a regulatory authority. Voluntary recalls are often seen as a sign of corporate responsibility and a commitment to patient safety.

  • Notification: Once a recall decision is made, the manufacturer must inform regulatory agencies, such as the Food and Drug Administration (FDA) in the United States. They must provide detailed information about the product, the nature of the defect, and the scope of the recall.

  • Recall Strategy: The manufacturer develops and implements a recall strategy, which includes notifying wholesalers, pharmacies, healthcare providers, and sometimes patients. They must also arrange for the safe return or destruction of the recalled product.

Legal and Ethical Obligations

Manufacturers have both legal and ethical obligations to act promptly. Failure to recall a defective medication can result in lawsuits, financial penalties, and severe damage to the company’s reputation. In extreme cases, company executives may face criminal charges if negligence is proven.

2. Regulatory Authorities: Oversight and Enforcement

While manufacturers are responsible for initiating most recalls, regulatory authorities play a crucial oversight role. In the United States, this responsibility falls primarily to the FDA; in Europe, it’s the European Medicines Agency (EMA); and in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA).

Key Roles of Regulatory Authorities

  • Review and Approval: Regulatory agencies review the manufacturer’s recall plan to ensure it is adequate and that all affected parties will be notified.

  • Classification: The FDA classifies recalls into three categories based on the level of risk:

    • Class I: A dangerous or defective product that could cause serious health problems or death.

    • Class II: A product that might cause a temporary health problem or pose a slight threat of a serious nature.

    • Class III: A product that is unlikely to cause any adverse health reaction but violates FDA labeling or manufacturing laws.

  • Public Notification: Regulatory authorities determine when and how to inform the public about recalls, especially if the product is widely used or poses a significant health risk.

  • Mandatory Recalls: While most recalls are voluntary, agencies like the FDA have the authority to mandate a recall if a company fails to act or if the risk is severe.

Monitoring and Follow-up

Regulatory bodies monitor the effectiveness of the recall, ensuring that all affected products are removed from the market and that the public is adequately protected. They may also conduct inspections or audits to verify compliance.

3. Pharmacies and Healthcare Providers: Implementing Recalls at the Point of Care

Pharmacies, hospitals, and healthcare providers are on the front lines when it comes to executing recalls. They play a critical role in ensuring that recalled medications are removed from circulation and that patients are informed.

Responsibilities of Pharmacies and Providers

  • Inventory Management: Pharmacies must promptly remove recalled products from their shelves and storage areas.

  • Patient Notification: When possible, pharmacies and healthcare providers notify patients who may have received the recalled medication, advising them on what steps to take.

  • Safe Disposal: They must ensure that recalled drugs are disposed of safely and in accordance with regulatory guidelines.

  • Record Keeping: Detailed records of the recall process must be maintained for regulatory compliance and future reference.

Interdisciplinary Collaboration

Pharmacy departments often lead interdisciplinary recall teams, working with nursing, medical staff, and hospital administration to coordinate a comprehensive response.

4. Consumers and Patients: Taking Action

Patients and consumers are the final link in the recall chain. While they are not responsible for initiating recalls, their cooperation is essential for the process to be effective.

What Patients Should Do

  • Stay Informed: Patients should pay attention to recall notices from pharmacies, healthcare providers, or regulatory agencies.

  • Follow Instructions: If they have received a recalled medication, they should follow instructions on returning or safely disposing of the product and consult their healthcare provider for alternatives.

  • Report Adverse Effects: Patients should report any adverse effects experienced from medications to their healthcare provider or directly to regulatory agencies.

Conclusion: A Collaborative Effort for Public Safety

Medication recalls are complex, multi-step processes involving manufacturers, regulatory authorities, healthcare providers, and patients. While manufacturers bear the primary responsibility for identifying and initiating recalls, regulatory agencies oversee and enforce these actions. Pharmacies and healthcare providers ensure that recalls are implemented at the point of care, and patients must respond appropriately to recall notices. Only through this collaborative effort can the safety and well-being of the public be protected when medication risks arise.